ジェネリック筋骨格系障害治療薬の世界市場レポート 2024年

ジェネリック筋骨格系障害治療薬の市場規模は近年力強く成長しています。2023年の6,000万米ドルから2024年には6.8%のCAGR（複合年間成長率）で6,000万米ドルに成長します。過去の期間に観察された成長は、筋骨格系障害の発生率、ヘルスケアを管理する規制環境、ヘルスケアインフラの発展、患者の意識向上と教育、経済的要因の影響などの要因によるものです。

アジア太平洋は、2023年のジェネリック筋骨格系障害治療薬市場において最大の地域でした。市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 筋骨格系疾患のジェネリック医薬品市場の特徴

第3章 筋骨格系疾患のジェネリック医薬品市場の動向と戦略

第4章 筋骨格系疾患のジェネリック医薬品市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の筋骨格系疾患のジェネリック医薬品市場規模と成長

• 世界のジェネリック筋骨格系疾患薬市場促進要因と制約
  • 市場の促進要因
  • 市場の抑制要因
• 世界のジェネリック筋骨格系疾患薬の市場規模実績と成長、2018年から2023年
• 世界のジェネリック筋骨格系疾患薬市場の規模と成長予測、2023～2028年、2033年

第6章 筋骨格系疾患のジェネリック医薬品市場セグメンテーション

• 世界の筋骨格系疾患ジェネリック医薬品市場、治療タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 薬
  • 治療
  • 手術
  • その他の治療タイプ
• 世界の筋骨格系疾患ジェネリック医薬品市場、疾患タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 変形性関節症
  • 関節リウマチ
  • 脊椎関節炎
  • 若年性特発性関節炎
  • 乾癬性関節炎
  • 線維筋痛症
  • 他の種類の障害
• 世界の筋骨格系疾患ジェネリック医薬品市場、投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • オーラル
  • 非経口
  • その他のルート
• 世界の筋骨格系疾患ジェネリック医薬品市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • ドラッグストア
  • オンライン薬局

第7章 筋骨格系疾患のジェネリック医薬品市場の地域および国分析

• 世界の筋骨格系疾患ジェネリック医薬品市場、地域別、実績および予測、2018年から2023年、2023年から2028年まで、2033年まで
• 世界の筋骨格系疾患ジェネリック医薬品市場、国別、実績および予測、2018年から2023年、2023年から2028年まで、2033年まで

第8章 アジア太平洋の筋骨格系疾患のジェネリック医薬品市場

第9章 中国の筋骨格系疾患のジェネリック医薬品市場

第10章 インドの筋骨格系疾患のジェネリック医薬品市場

第11章 日本の筋骨格系疾患のジェネリック医薬品市場

第12章 オーストラリアの筋骨格系疾患のジェネリック医薬品市場

第13章 インドネシアの筋骨格系疾患のジェネリック医薬品市場

第14章 韓国の筋骨格系疾患のジェネリック医薬品市場

第15章 西欧の筋骨格系疾患のジェネリック医薬品市場

第16章 英国の筋骨格系疾患のジェネリック医薬品市場

第17章 ドイツの筋骨格系疾患のジェネリック医薬品市場

第18章 フランスの筋骨格系疾患のジェネリック医薬品市場

第19章 イタリアの筋骨格系疾患のジェネリック医薬品市場

第20章 スペインの筋骨格系疾患のジェネリック医薬品市場

第21章 東欧の筋骨格系疾患のジェネリック医薬品市場

第22章 ロシアの筋骨格系疾患のジェネリック医薬品市場

第23章 北米の筋骨格系疾患のジェネリック医薬品市場

第24章 米国の筋骨格系疾患のジェネリック医薬品市場

第25章 カナダの筋骨格系疾患のジェネリック医薬品市場

第26章 南米の筋骨格系疾患のジェネリック医薬品市場

第27章 ブラジルの筋骨格系疾患のジェネリック医薬品市場

第28章 中東の筋骨格系疾患のジェネリック医薬品市場

第29章 アフリカの筋骨格系疾患のジェネリック医薬品市場

第30章 ジェネリック筋骨格系疾患薬市場の競合情勢と企業プロファイル

• ジェネリック筋骨格系疾患薬市場の競合情勢
• ジェネリック筋骨格系疾患薬市場の企業プロファイル
  • Pfizer Inc.
  • Sanofi SA
  • Eli Lilly and Company
  • Ampio Pharmaceuticals Inc.
  • Amgen Inc.

第31章 世界の筋骨格系疾患のジェネリック医薬品市場の競合ベンチマーキング

第32章 世界の筋骨格系疾患のジェネリック医薬品市場競争力ダッシュボード

第33章 筋骨格系疾患のジェネリック医薬品市場における主要な合併と買収

第34章 筋骨格系疾患のジェネリック医薬品市場の将来展望と可能性分析

第35章 付録

“Generic Musculoskeletal Disorders Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generic musculoskeletal disorders drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generic musculoskeletal disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The generic musculoskeletal disorders drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Treatment Type: Medication; Therapy; Surgery; Other Treatment Types
• 2) By Disorder Type: Osteoarthritis; Rheumatoid Arthritis; Spondylarthritis; Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Fibromyalgia; Other Disorder Types
• 3) By Route of Administration: Oral; Parenteral; Other Routes
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Drug Store; Online Pharmacy
• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Eli Lilly and Company; Ampio Pharmaceuticals Inc.; Amgen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Generic musculoskeletal disorders drugs play a crucial role in managing conditions related to the musculoskeletal system, providing relief from pain, stiffness in muscles, and treating muscle spasms.

The main treatments for generic musculoskeletal disorders drugs include medication, therapy, surgery, and other interventions. Medications come in various forms, containing one or more active chemicals and potential inactive components. They can be administered through oral, parenteral, and other routes to address conditions such as osteoarthritis, rheumatoid arthritis, spondylarthritis, juvenile idiopathic arthritis, psoriatic arthritis, fibromyalgia, and other musculoskeletal disorders. These drugs are distributed through different channels, including hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.

The generic musculoskeletal disorders drugs market research report is one of a series of new reports from The Business Research Company that provides generic musculoskeletal disorders drugs market statistics, including generic musculoskeletal disorders drugs industry global market size, regional shares, competitors with a generic musculoskeletal disorders drugs market share, detailed generic musculoskeletal disorders drugs market segments, market trends and opportunities, and any further data you may need to thrive in the generic musculoskeletal disorders drugs industry. This generic musculoskeletal disorders drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generic musculoskeletal disorders drugs market size has grown strongly in recent years. It will grow from $0.06 billion in 2023 to $0.06 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth observed in the historical period can be attributed to factors such as the incidence of musculoskeletal disorders, the regulatory environment governing healthcare, development in healthcare infrastructure, increased patient awareness and education, and the influence of economic factors.

The generic musculoskeletal disorders drugs market size is expected to see strong growth in the next few years. It will grow to $0.08 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth in the forecast period can be attributed to factors such as population growth and aging demographics, emerging markets, advancements in precision medicine and personalized therapies, ongoing healthcare reforms, and global health trends. Major trends expected in the forecast period include the integration of technology in treatment approaches, government initiatives and healthcare policies, a focus on alternatives for pain management, an increased adoption of biosimilars, and advancements in the development of generic drugs.

The anticipated high prevalence of arthritis is set to drive the growth of the generic musculoskeletal disorders drugs market. Arthritis, characterized by joint tenderness, swelling, pain, and stiffness, necessitates the use of generic musculoskeletal disorders drugs to alleviate symptoms. These drugs are designed to relieve pain, stiffness, and muscle spasms associated with arthritis. According to the Centers for Disease Control and Prevention, an estimated 78.4 million adults aged 18 and older, constituting 25.9% of the total adult population, are projected to be diagnosed with arthritis by 2040. Hence, the pervasive occurrence of arthritis is a significant driver for the growth of the generic musculoskeletal disorders drugs market.

The increasing adoption of telemedicine is expected to further propel the growth of the generic musculoskeletal disorders drugs market. Telemedicine involves leveraging telecommunications and digital technologies to provide remote healthcare services, facilitating virtual consultations between patients and healthcare providers. The adoption of telemedicine enhances accessibility, convenience, and continuity of care for patients with musculoskeletal disorders. For instance, data from FAIR Health Inc. in April 2023 indicates a 7.3% increase in national telehealth use, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Thus, the growing embrace of telemedicine contributes to the expansion of the generic musculoskeletal disorders drugs market.

Strategic partnerships emerge as a prominent trend in the generic musculoskeletal disorders drugs market, with companies entering partnerships to bolster their market positions. A notable example is the collaboration between Mitsubishi Tanabe Pharma Corporation, a Japanese pharmaceutical company, and Eli Lilly and Company, a U.S.-based pharmaceutical company, aimed at broadening product lines and providing effective treatments for conditions such as diabetes. Additionally, Pfizer Inc., a major pharmaceutical and biotechnology corporation, partnered with Alex Therapeutics, a Swedish digital therapeutics company, in February 2022, offering patients evidence-based, clinically verified, and tailored digital therapeutics through this strategic alliance.

Major companies operating in the generic musculoskeletal disorders drugs market are placing emphasis on innovative products to drive revenue growth. An example is the introduction of the non-permanent ossiofiber compression staple by Ossio Inc., a U.S.-based company specializing in orthopedic and musculoskeletal applications. This medical device, designed for fracture fixation and bone fusion in orthopedic surgeries, offers temporary stability and compression to promote bone healing and fusion. The non-permanent ossiofiber compression staple presents an alternative to traditional implants and permanent metal hardware.

In October 2023, Amgen Inc., a U.S.-based biopharmaceutical company, acquired Horizon Therapeutics Plc for $27.8 billion. This acquisition enables Amgen to diversify its product line and offer treatments for severe inflammatory, autoimmune, and rare disorders. Horizon Therapeutics Plc, an Ireland-based biopharmaceutical company, contributes to Amgen's commitment to utilizing biology to address life-threatening disorders.

Major companies operating in the generic musculoskeletal disorders drugs market report are Pfizer Inc., Sanofi S.A., Eli Lilly and Company, Ampio Pharmaceuticals Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca plc, Mitsubishi Tanabe Pharma Corporation, Horizon Therapeutics plc, The Procter & Gamble Company, Eisai Co. Ltd., Biogen Inc., Sino Biopharmaceutical Limited, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Bayer AG, Mylan Pharmaceuticals Inc., Taisho Pharmaceutical Holdings Co. Ltd., Egalet Corporation, Mesoblast Limited, Biosplice Therapeutics Inc., Vertex Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Flexion Therapeutics Inc., .

Asia-Pacific was the largest region in the generic musculoskeletal disorders drugs market in 2023. The regions covered in the generic musculoskeletal disorders drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the generic musculoskeletal disorders drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generic musculoskeletal disorders drugs market consists of sales of analgesics, oral non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anti-neuropathic pain medications, corticosteroids, and disease modifying anti-rheumatic drugs (DMARDs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Generic Musculoskeletal Disorders Drugs Market Characteristics

3. Generic Musculoskeletal Disorders Drugs Market Trends And Strategies

4. Generic Musculoskeletal Disorders Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Generic Musculoskeletal Disorders Drugs Market Size and Growth

• 5.1. Global Generic Musculoskeletal Disorders Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Generic Musculoskeletal Disorders Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Generic Musculoskeletal Disorders Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Generic Musculoskeletal Disorders Drugs Market Segmentation

• 6.1. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Medication
• Therapy
• Surgery
• Other Treatment Types
• 6.2. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Osteoarthritis
• Rheumatoid Arthritis
• Spondylarthritis
• Juvenile Idiopathic Arthritis
• Psoriatic Arthritis
• Fibromyalgia
• Other Disorder Types
• 6.3. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Other Routes
• 6.4. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Drug Store
• Online Pharmacy

7. Generic Musculoskeletal Disorders Drugs Market Regional And Country Analysis

• 7.1. Global Generic Musculoskeletal Disorders Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Generic Musculoskeletal Disorders Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Generic Musculoskeletal Disorders Drugs Market

• 8.1. Asia-Pacific Generic Musculoskeletal Disorders Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Generic Musculoskeletal Disorders Drugs Market

• 9.1. China Generic Musculoskeletal Disorders Drugs Market Overview
• 9.2. China Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Generic Musculoskeletal Disorders Drugs Market

• 10.1. India Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Generic Musculoskeletal Disorders Drugs Market

• 11.1. Japan Generic Musculoskeletal Disorders Drugs Market Overview
• 11.2. Japan Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Generic Musculoskeletal Disorders Drugs Market

• 12.1. Australia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Generic Musculoskeletal Disorders Drugs Market

• 13.1. Indonesia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Generic Musculoskeletal Disorders Drugs Market

• 14.1. South Korea Generic Musculoskeletal Disorders Drugs Market Overview
• 14.2. South Korea Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Generic Musculoskeletal Disorders Drugs Market

• 15.1. Western Europe Generic Musculoskeletal Disorders Drugs Market Overview
• 15.2. Western Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Generic Musculoskeletal Disorders Drugs Market

• 16.1. UK Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Generic Musculoskeletal Disorders Drugs Market

• 17.1. Germany Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Generic Musculoskeletal Disorders Drugs Market

• 18.1. France Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Generic Musculoskeletal Disorders Drugs Market

• 19.1. Italy Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Generic Musculoskeletal Disorders Drugs Market

• 20.1. Spain Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Generic Musculoskeletal Disorders Drugs Market

• 21.1. Eastern Europe Generic Musculoskeletal Disorders Drugs Market Overview
• 21.2. Eastern Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Generic Musculoskeletal Disorders Drugs Market

• 22.1. Russia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Generic Musculoskeletal Disorders Drugs Market

• 23.1. North America Generic Musculoskeletal Disorders Drugs Market Overview
• 23.2. North America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Generic Musculoskeletal Disorders Drugs Market

• 24.1. USA Generic Musculoskeletal Disorders Drugs Market Overview
• 24.2. USA Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Generic Musculoskeletal Disorders Drugs Market

• 25.1. Canada Generic Musculoskeletal Disorders Drugs Market Overview
• 25.2. Canada Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Generic Musculoskeletal Disorders Drugs Market

• 26.1. South America Generic Musculoskeletal Disorders Drugs Market Overview
• 26.2. South America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Generic Musculoskeletal Disorders Drugs Market

• 27.1. Brazil Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Generic Musculoskeletal Disorders Drugs Market

• 28.1. Middle East Generic Musculoskeletal Disorders Drugs Market Overview
• 28.2. Middle East Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Generic Musculoskeletal Disorders Drugs Market

• 29.1. Africa Generic Musculoskeletal Disorders Drugs Market Overview
• 29.2. Africa Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Generic Musculoskeletal Disorders Drugs Market Competitive Landscape And Company Profiles

• 30.1. Generic Musculoskeletal Disorders Drugs Market Competitive Landscape
• 30.2. Generic Musculoskeletal Disorders Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Sanofi S.A.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Eli Lilly and Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Ampio Pharmaceuticals Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Amgen Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Generic Musculoskeletal Disorders Drugs Market Competitive Benchmarking

32. Global Generic Musculoskeletal Disorders Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Generic Musculoskeletal Disorders Drugs Market

34. Generic Musculoskeletal Disorders Drugs Market Future Outlook and Potential Analysis

• 34.1 Generic Musculoskeletal Disorders Drugs Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Generic Musculoskeletal Disorders Drugs Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Generic Musculoskeletal Disorders Drugs Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer